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Summary A number of amiloride analogs can sensitise wild type Chinese Hamster ovary (CHO) cells to the
cytotoxic action of vinblastine, daunomycin, puromycin or colchicine. Some of these analogs also have weak
sensitising effects on the multidrug resistant CHO cell line, CHRC5. The unusual feature of most of the active
amiloride analogs is that they are more potent in reversing the intrinsic multidrug resistance (MDR)
phenotype of CHO cells than their acquired MDR characteristic. Human HeLa cells that do not exhibit
intrinsic MDR are not affected by these agents. Several of the amiloride analogs have a greater effect in
increasing adriamycin uptake in wild type CHO cells than they do with CHRC5 cells. The differential effect of
amiloride analogs on intrinsic versus acquired MDR characteristics of Chinese hamster cells suggests some
differences in the underlying resistance mechanisms.
Cells can be selected for resistance to cytotoxic drugs. Fre-
quently this drug resistance will be pleiotropic. One class of
mutant selected in mammalian cells exhibits increased resist-
ance to a variety of naturally occurring and semi-synthetic
cytotoxic drugs including vinca alkaloids, colchicine,
adriamycin, daunomycin and puromycin (Beidler & Meyers,
1989; Endicott & Ling, 1989; Juranka et al., 1989). This form
of multidrug resistance (MDR) has been referred to as
acquired resistance. In addition, it has recently been shown
that certain wild type cells, particular those derived from
rodents, can be made more sensitive to cytotoxic drugs by
agents (e.g. verapamil) which reverse MDR (Gupta, 1988).
This expression of resistance, to the same group of drugs as
seen in the MDR mutant, does not require prior selection
with cytotoxic agents and has been termed intrinsic MDR
(Gupta, 1988). In this work, for the first time, we show that
several analogs of amiloride can reverse intrinsic MDR with-
out greatly affecting the acquired MDR.
Amiloride is an inhibitor of Na+/H+ antiport. The activity
of this ion transporter is elevated in drug resistant cell lines
(Boscoboinik et al., 1990). Analogs of amiloride vary greatly
in the potency and specificity by which they inhibit this
antiporter (Kleyman & Cragoe, 1988). Inhibition of Na+/H+
transport leads to acidification of the intracellular pH (pHi).
Positively charged cytotoxic drugs which can permeate the
cell membrane will accumulate on the acidic side of the
membrane. Since pH, is elevated in resistant cells compared
to wild type cells (Keizer & Joenje, 1989; Boscoboinik et al.,
1990), it seemed possible that acidification of pH,, through
inhibition of the Na+/H+ antiporter, could contribute to the
sensitisation of drug resistant cell lines.
Materials
Amiloride analogs were synthesised for this study by
previously described methods (Cragoe et al., 1967). Minimum
essential medium (a-MEM) containing L-glutamine and all
four ribonucleosides and x-deoxyribonucleosides (a-MEM +
nucleosides), faetal bovine serum, penicillin, streptomycin,
and amphotericin were obtained from Gibco, Grand Island,
NY; trypsin from Difco, Detroit, MI; methylene blue from
Fisher Scientific Co., Fairlawn, NY; adriamycin, HCI, and
vinblastine sulfate were purchased from Sigma Chemical Co.,
St. Louis, MO.
Cell lines and culture conditions
The parental Chinese hamster ovary cell line which requires
proline for growth (Pro-) is referred to as wild type (WT) in
our work. The cell line AUXB1 which in addition to proline
requires glycine, adenosine and thymidine for growth, was
derived from Pro- WT cells by a single mutational alteration
(McBurney & Whitmore, 1974). The Pro- and AUXBI cell
lines show similar sensitivity towards various drugs used in
the present study (Gupta, R.S., unpublished results). The cell
line CHRC5 was derived from AUXBI after three successive
selections in presence of increasing concentrations of col-
chicine (Ling & Thompson, 1974). The CHRC5 cell line
(Bech-Hansen et al., 1976) was kindly provided by Dr Victor
Ling of the Ontario Cancer Institute, Toronto, Ontario.
HeLa (clone S3) is a human cell line established from a
cervical carcinoma (Puck et al., 1956). All of the above cell
lines were grown as monolayer cultures in a-MEM +
nucleosides supplemented with 5-10% foetal bovine serum
at 37°C in a humidified incubator in an atmosphere of 95%
air and 5% CO2. The cell lines were routinely grown in the
absence of any selective drug without loss of resistance.
Clonogenic assay
The effect of various agents on the reversal of the drug-
resistance was examined by determining the cloning
efficiencies of the parental and resistant cell lines in the
presence of different concentrations of either vinblastine,
daunomycin, puromycin or colchicine, in the absence and
presence of the amiloride analogs. In these experiments,
which were carried out in 24-well tissue culture dishes, 0.5 ml
of 11 progressive dilutions of cytotoxic drug (made at two
times the final concentrations in growth medium) were added
to duplicate wells of 24-well dishes. These dilutions were
chosen to cover a range of concentrations both above and
below the cytotoxic level either in the presence or in the
absence of sensitiser. Generally, 11 different concentrations
of the drug, in addition to a control without any drug, were
employed. The single cell suspensions of the cell lines were
suitably diluted (based on cell count measurement done by
Coulter counter), and 0.5 ml of these suspensions, containing
200 or 500 cells together with a fixed concentration of
amiloride analog were then added to the wells of 24-well
dishes. The experiments were carried out in parallel with and
without the reversing agents. Amiloride analog solutions
were made in dimethyl sulfoxide (DMSO); vinblastine sulfate
solutions were made in ethanol and diluted in medium. The
final concentration of solvent present in the wells did not
exceed 2% and in most cases was below 0.2%. The control
dishes (i.e. without reversing agent) received an equivalent
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Table I Structure and ion transport inhibitory activity of amiloride and its analogs (active compounds indicated by
asterisk)
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amount of the appropriately diluted solvent. At these concen-
trations, the solvents had no significant effect on cell viability
or the number of clones formed. The cytotoxicity of
amiloride analogs towards various cell lines was determined
in separate clonogenic assays. Only concentrations of
amiloride analogs below the 50% cytotoxic level were used in
the drug sensitivity tests. The dishes were incubated for 6-10
days (about 6-7 days for CHO and 8-10 days for HeLa
cells) at 37°C in 5% C02-95% air incubator. By this time,
each colony in the control wells generally has 100 or more
cells. Subsequently, the dishes were stained for about 30 min
with 0.5% methylene blue in 50% methanol and the number
of colonies (aggregates of >25 cells) in each well was scored.
From the average numbers of colonies observed in the
presence of different drug concentrations, the D1o values (i.e.
drug concentrations which reduced cloning efficiency to ap-
proximately 10% of that in the absence of any drug), of
different cell lines in the absence and presence of various
reversing agents were determined. The degree of resistance of
any cell line was determined from the ratio of D1O values for
the mutant vs parental cell lines. The sensitising effect of
reversing agents was calculated from the ratios of D1o values
observed in the absence and presence of reversing drug. Each
clonogenic assay was repeated in at least two independent
experiments. Reproducibility of the D1o values in independent
assays was generally within 25%.
Drug accumulation
Cellular uptake of adriamycin was measured by fluorescence
according to the method of Ganapathi and Grabowski (1983)
as modified by Chambers et al. (1989). Briefly, cells were250 R.F. EPAND et al.
grown in culture medium without the addition of drugs until
the 10 cm diameter culture dishes were covered with a
monolayer of cells (about 9 x 106 cells). Then a solution of
adriamycin in H20 was added to all plates so as to give a
final concentration of 10 gLM. Half of the dishes were used as
control. The other half, a small volume of an amiloride
analog solution in DMSO was added. The solvent concentra-
tion was always below 1%. All dishes were incubated at 37°C
in a 5% CO2 atmosphere for 0, 1, 2 and 3 h, in duplicate.
After the designated periods of incubation, the dishes were
washed twice with phosphate buffered saline and then ex-
tracted with 9 ml 0.3 M HCI in 50% methanol for 1-2 min.
The fluorescence was then measured using the ratio mode in
a Perkin Elmer MPF-44 fluorimeter with an excitation of
470 nm and an emission of 585 nm.
Results
A number of analogs of amiloride were tested for their
ability to reverse multidrug resistance in Chinese hamster
ovary (CHO) cells. These amiloride analogs (Table I) have
been previously characterised for their effects on ion trans-
port (Kleyman & Cragoe, 1988; Cragoe and coworkers,
unpublished results). Of the many compounds tested, several
had activity as sensitisers (Table II). That is, concentrations
of amiloride analogs which alone had minimal effect on the
number of colonies formed, sensitised cells to the cytotoxic
action of vinblastine. The number of colonies formed in the
presence of cytotoxic drug plus amiloride analog was always
compared with control wells which contained only the
amiloride analog. In general, these compounds were more
effective in reversing the intrinsic MDR characteristic of
CHO cells than in reversing acquired resistance. Several of
the compounds which specifically reversed intrinsic resistance
to vinblastine, were tested against other cytotoxic agents
(Table III). As with vinblastine, intrinsic but not acquired
resistance to these other cytotoxic drugs is reversed by the
amiloride analogs. In addition, these sensitisers have no effect
on HeLa cells (Table III), a cell line which does not exhibit
intrinsic MDR (Gupta, 1988). This was also found when
vinblastine was used as the cytotoxic agent (data not shown).
One of the causes for resistance to cytotoxic drugs is a
decreased accumulation of cytotoxic agent. This could ex-
plain why wild type cells take up more adriamycin than do
resistant cells (Figure 1). Panel a shows an enhancement of
drug uptake in both WT and CHRC5 cell lines in the
presence of DMP or naphthamil. This is consistent with the
partial reversal of both intrinsic and acquired resistance by
these sensitisers (Table II). However, the effects of phenamil,
HPA and MIBA on adriamycin uptake (Figure 1, panel b)
are specific for the WT cell line, with no increase in uptake
seen with the resistant cell line. These three drugs were
effective in reversing only intrinsic and not acquired resist-
ance (Table II).
Table II Analogs active in sensitising Chinese hamster ovary cells
to vinblastine
D50 Concentration Fold sensitisation
Analog (riM) t4M WT CHRCS
No addition - i Ib
MACMA >400 100 1.4 1.1
200 3.3 1
MTBA 12 10 2.0 1
MIBA 12 10 4.5 1
CBDMB 0.6 0.5 3 1
Phenamil 50 25 3.5 1
DBC > 50 50 3 4.5
Naphthamil 6 2.8 1 2.5
5.6 2.5 10
DMP 30 15 5 10
BTMB 5 4 5 2
HPA 80 77 10 2
Dibenzamil 3 1.8 2.5 1
aD_j - concentration of amiloride analog which reduces cloning
efficiency to 50% of control. bEffect of sensitisers compared with
same cell line in the absence of drug. The D1o (i.e. the vinblastine
concentration which reduced the cloning efficiency to approximately
10% of that in the absence of any drug) was 12 nm for WT and
123 nM for CHRC5.
Discussion
The observation that some of the amiloride analogs are more
effective against intrinsic MDR than acquired MDR is of
particular interest. These are the only sensitisers that have
been shown to affect intrinsic resistance more than acquired
resistance. In contrast to these compounds, other agents such
as verapamil, reserpine or cyclosporin concomitantly reverse
both intrinsic as well as acquired MDR (Tsuruo et al., 1981;
Twentyman et al., 1987; Gupta, 1988 and unpublished re-
sults). Not only are sensitisers generally common to both
intrinsic and acquired resistance, but also the drugs to which
the cells are resistant are the same.
The mechanism of acquired MDR has been studied more
extensively. Cell lines with acquired MDR overexpress a
170 kDa membrane glycoprotein, the P-glycoprotein (van der
Bliek et al., 1986; Fojo et al., 1987; Scheper et al., 1988;
Juranka et al., 1989). This P-glycoprotein is believed to func-
tion as an ATP-dependent efflux pump for cytotoxic drugs
(Juranka et al., 1989). However, it is not clear that this is the
sole mechanism for acquired MDR and several discrepancies
between the level of P-glycoprotein expression and the level
of acquired resistance have appeared in the literature. In
addition, little is known about the mechanism of sensitisation
or reversal of acquired resistance. It has been suggested that
sensitisers increase drug accumulation by competing with
cytotoxic drugs for sites on the P-glycoprotein efflux pump
(Horio et al., 1988). However, one sensitiser, cyclosporin A,
has been shown to reverse acquired MDR in some cell lines
but not in DC3F/ADX cells, despite the fact that these cells
overexpress P-glycoprotein (Boscoboinik et al., 1990).
Table III Sensitisation of Chinese hamster ovary cells to other cytotoxic
agents
Cytotoxic Reversing" D,O value (jgml-') andfold sensitisation
drug agent WT (CHO) CHRC5 HeLa
Daunomycin NONE 0.025 (1) 0.30 (1) 0.003 (1)
MTBA 0.015 (1.7) 0.30 (1) 0.003 (1)
MIBA 0.015 (1.7) 0.30 (1) 0.003 (1)
CBDMB 0.007 (3.6) 0.30 (1) 0.003 (1)
Puromycin NONE 3.5 (1) 25 (1) 0.15 (1)
MIBA 1.4 (2.5) 25 (1) 0.15 (1)
CBDMB 1.1 (3.2) 25 (1) 0.15 (1)
Colchicine NONE 0.045 (1) 2.0 (1) 0.002 (1)
CBDMB 0.017 (2.6) 2.0 (1) 0.002 (1)
aMTBA, MIBA and CBDMB were used at the same concentration as
indicated in Table II.MULTIDRUG RESISTANCE AND AMILORIDE ANALOGS 251
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Figure 1 Effect of amiloride analogs on the accumulation of
adriamycin by wild type CHO cells (solid lines, open symbols)
and drug resistant CHIC5 cells (dashed line, filled symbols). a,
No drug (0,0); naphthamil (0,CI) and DMP (A,A). b, No
drug (0,0); MIBA (0,0); HPA (*,0) and phenamil (A,A).
Adriamycin concentration: 100Llm; concentration of sensitiser:
10I1M, except for HPA where 77p1m was used.
The mechanism of intrinsic MDR is even less well under-
stood. Based on very similar characteristics of intrinsic MDR
and acquired MDR (with regard to drug cross resistance
pattern and reversal by agents such as verapamil, reserpine,
etc.), the mechanisms responsible for the two should be
related. Therefore, differences in P-glycoprotein expression
between human and rodent cells may be responsible for the
intrinsic MDR phenotype of the latter cells. In this context,
our observation that the intrinsic and acquired MDR
phenotypes differ with regard to their reversal by amiloride
analogs points to some subtle differences in the resistance
mechanism. It should however, be mentioned that acquired
MDR cell lines which overexpress P-glycoprotein are also
known to differ in their reversal characteristics by cyclosporin
A (Boscoboinik et al., 1990). The different reversing agents
may provide a valuable probe for examining the hetero-
geneity of the MDR phenotype and for investigating the
underlying mechanism(s).
Although some of the drug sensitising amiloride analogs
are potent inhibitors of Na+/H+ antiport, this does not seem
to be their mechanism of action since some antiport
inhibitors are not sensitisers and some sensitisers are not
inhibitors. In addition, although three of the amiloride
analogs which act as sensitisers are potent Na+ channel
inhibitors, i.e. phenamil, HPA and DMP, this also does not
account for the mechanism of action of all of the amiloride
analogs. It is, of course, possible that different sensitisers
function by different mechanisms. However, a simpler and
more likely explanation is that this group of related com-
pounds are among the several hydrophobic and cationic
amphiphiles that reverse multidrug resistance and that their
action is independent of inhibition of ion fluxes.
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